Overview

Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG

Status:
Completed
Trial end date:
2018-01-30
Target enrollment:
Participant gender:
Summary
Proper bowel cleansing before colonoscopy is an important factor to increase the detection rate of lesions. Low volume polyethylene glycol (PEG) plus ascorbic (PEG-Asc) has reduced the dosage of previous bowel preparation agent, but it still presents discomfort to patients. The aim of this study was to confirm the efficacy and convenience of volume reduction of PEG-Asc by adding bisacodyl suppository at the same day by compared with conventional 2L PEG-Asc.
Phase:
N/A
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Bisacodyl